BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23009291)

  • 1. Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue.
    Ribeiro R; Monteiro C; Catalán V; Hu P; Cunha V; Rodríguez A; Gómez-Ambrosi J; Fraga A; Príncipe P; Lobato C; Lobo F; Morais A; Silva V; Sanches-Magalhães J; Oliveira J; Pina F; Lopes C; Medeiros R; Frühbeck G
    BMC Med; 2012 Sep; 10():108. PubMed ID: 23009291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro.
    Ribeiro R; Monteiro C; Cunha V; Oliveira MJ; Freitas M; Fraga A; Príncipe P; Lobato C; Lobo F; Morais A; Silva V; Sanches-Magalhães J; Oliveira J; Pina F; Mota-Pinto A; Lopes C; Medeiros R
    J Exp Clin Cancer Res; 2012 Apr; 31(1):32. PubMed ID: 22469146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between obesity and prostate cancer: from genetics to disease treatment and prevention.
    Lughezzani G
    BMC Med; 2012 Sep; 10():109. PubMed ID: 23009325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenome-wide DNA methylation profiling of periprostatic adipose tissue in prostate cancer patients with excess adiposity-a pilot study.
    Cheng Y; Monteiro C; Matos A; You J; Fraga A; Pereira C; Catalán V; Rodríguez A; Gómez-Ambrosi J; Frühbeck G; Ribeiro R; Hu P
    Clin Epigenetics; 2018; 10():54. PubMed ID: 29692867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma.
    Ribeiro R; Monteiro C; Silvestre R; Castela A; Coutinho H; Fraga A; Príncipe P; Lobato C; Costa C; Cordeiro-da-Silva A; Lopes JM; Lopes C; Medeiros R
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1155-62. PubMed ID: 23038706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprostatic adipose tissue from obese prostate cancer patients promotes tumor and endothelial cell proliferation: a functional and MR imaging pilot study.
    Venkatasubramanian PN; Brendler CB; Plunkett BA; Crawford SE; Fitchev PS; Morgan G; Cornwell ML; McGuire MS; Wyrwicz AM; Doll JA
    Prostate; 2014 Feb; 74(3):326-35. PubMed ID: 24571013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancer.
    Mangiola S; Stuchbery R; Macintyre G; Clarkson MJ; Peters JS; Costello AJ; Hovens CM; Corcoran NM
    Endocr Relat Cancer; 2018 May; 25(5):569-581. PubMed ID: 29592867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprostatic adipose inflammation is associated with high-grade prostate cancer.
    Gucalp A; Iyengar NM; Zhou XK; Giri DD; Falcone DJ; Wang H; Williams S; Krasne MD; Yaghnam I; Kunzel B; Morris PG; Jones LW; Pollak M; Laudone VP; Hudis CA; Scher HI; Scardino PT; Eastham JA; Dannenberg AJ
    Prostate Cancer Prostatic Dis; 2017 Dec; 20(4):418-423. PubMed ID: 28653675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenografts.
    Lo JC; Clark AK; Ascui N; Frydenberg M; Risbridger GP; Taylor RA; Watt MJ
    Oncotarget; 2016 Jul; 7(30):47650-47662. PubMed ID: 27351281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dissemination of prostate cancer: a way paved of fat].
    Laurent V; Guérard A; Toulet A; Valet P; Malavaud B; Muller C
    Med Sci (Paris); 2016; 32(6-7):563-5. PubMed ID: 27406759
    [No Abstract]   [Full Text] [Related]  

  • 11. Human Periprostatic Adipose Tissue: Secretome from Patients With Prostate Cancer or Benign Prostate Hyperplasia.
    Sacca PA; Mazza ON; Scorticati C; Vitagliano G; Casas G; Calvo JC
    Cancer Genomics Proteomics; 2019; 16(1):29-58. PubMed ID: 30587498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRP10, PGK1 and RPLP0: Best Reference Genes in Periprostatic Adipose Tissue under Obesity and Prostate Cancer Conditions.
    Pérez-Gómez JM; Porcel-Pastrana F; De La Luz-Borrero M; Montero-Hidalgo AJ; Gómez-Gómez E; Herrera-Martínez AD; Guzmán-Ruiz R; Malagón MM; Gahete MD; Luque RM
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of adipocytokines and periprostatic adiposity measurement parameters on prostate cancer aggressiveness.
    Zhang Q; Sun LJ; Qi J; Yang ZG; Huang T
    Asian Pac J Cancer Prev; 2014; 15(4):1879-83. PubMed ID: 24641424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness.
    Finley DS; Calvert VS; Inokuchi J; Lau A; Narula N; Petricoin EF; Zaldivar F; Santos R; Tyson DR; Ornstein DK
    J Urol; 2009 Oct; 182(4):1621-7. PubMed ID: 19683746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprostatic adipose tissue and prostate cancer progression: new insights into the tumor microenvironment.
    Toren P; Venkateswaran V
    Clin Genitourin Cancer; 2014 Feb; 12(1):21-6. PubMed ID: 24269373
    [No Abstract]   [Full Text] [Related]  

  • 16. Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?
    Zulian A; Cancello R; Micheletto G; Gentilini D; Gilardini L; Danelli P; Invitti C
    Gut; 2012 Jan; 61(1):86-94. PubMed ID: 21930728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine.
    Passos GR; de Oliveira MG; Ghezzi AC; Mello GC; Levi D'Ancona CA; Teixeira SA; Muscará MN; Grespan Bottoli CB; Vilela de Melo L; de Oliveira E; Antunes E; Mónica FZ
    Front Pharmacol; 2023; 14():1145860. PubMed ID: 37492091
    [No Abstract]   [Full Text] [Related]  

  • 18. Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer.
    Nassar ZD; Aref AT; Miladinovic D; Mah CY; Raj GV; Hoy AJ; Butler LM
    BJU Int; 2018 May; 121 Suppl 3():9-21. PubMed ID: 29460324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer].
    Qu YY; Dai B; Chang K; Kong YY; Gu CY; Zhang GM; Wan FN; Wang HK; Zhang HL; Zhu Y; Ye DW
    Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1089-93. PubMed ID: 24499718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRS measured fatty acid composition of periprostatic adipose tissue correlates with pathological measures of prostate cancer aggressiveness.
    Iordanescu G; Brendler C; Crawford SE; Wyrwicz AM; Venkatasubramanian PN; Doll JA
    J Magn Reson Imaging; 2015 Sep; 42(3):651-7. PubMed ID: 25522916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.